These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 24205533)
1. Types of blood cancers--and new molecular diagnostics. Dash DP; Janasik M MLO Med Lab Obs; 2013 Aug; 45(8):8, 10, 12. PubMed ID: 24205533 [No Abstract] [Full Text] [Related]
2. The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis. Anastasi J Hematol Oncol Clin North Am; 2009 Aug; 23(4):693-708. PubMed ID: 19577165 [TBL] [Abstract][Full Text] [Related]
3. Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders. Bench AJ; Erber WN; Scott MA Clin Lab Haematol; 2005 Jun; 27(3):148-71. PubMed ID: 15938721 [TBL] [Abstract][Full Text] [Related]
12. The diagnostic interface between histology and molecular tests in myeloproliferative disorders. Tefferi A; Vardiman JW Curr Opin Hematol; 2007 Mar; 14(2):115-22. PubMed ID: 17255788 [TBL] [Abstract][Full Text] [Related]
13. Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative. Loscocco GG; Mannelli F; Guglielmelli P; Paoli C; Marone I; Cucci R; Coltro G; Sordi B; Albano F; Breccia M; De Stefano V; Finazzi G; Iurlo A; Martino B; Palandri F; Passamonti F; Siragusa S; Mannelli L; Fantoni D; Fazi P; Amadori S; Vignetti M; Barbui T; Vannucchi AM Am J Hematol; 2019 Sep; 94(9):E239-E242. PubMed ID: 31179561 [No Abstract] [Full Text] [Related]
14. [Changes of the WHO classification of myeloid neoplasms in the context of the 2016 revision]. Marcinek J; Balhárek T; Plank L Cesk Patol; 2017; 53(3):118-121. PubMed ID: 28937778 [TBL] [Abstract][Full Text] [Related]
15. [Towards better understanding of hematolymphoid malignancies--based on the WHO-2008 classification: summary]. Tohyama K Rinsho Byori; 2011 May; 59(5):502-3. PubMed ID: 21706866 [TBL] [Abstract][Full Text] [Related]
16. Clinical applications of molecular genetic testing in hematologic malignancies: advantages and limitations. Bagg A Hum Pathol; 2003 Apr; 34(4):352-8. PubMed ID: 12733115 [No Abstract] [Full Text] [Related]
17. [Optimising therapy in patients with haematological malignancies]. Dumontet C Bull Cancer; 2008 Oct; 95(10):959-62. PubMed ID: 19004726 [TBL] [Abstract][Full Text] [Related]
18. [Chromosomal analysis, fluorescence in situ hybridization method, and spectral karyotyping in hematologic malignancies]. Nara N Rinsho Byori; 2003 Jun; Suppl 126():124-30. PubMed ID: 12905952 [No Abstract] [Full Text] [Related]